Cargando…

PPARs and Anticancer Therapies

Detalles Bibliográficos
Autores principales: Robbins, Michael E. C., Linard, Christine, Panigrahy, Dipak
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896836/
https://www.ncbi.nlm.nih.gov/pubmed/20614003
http://dx.doi.org/10.1155/2010/536415
_version_ 1782183393045250048
author Robbins, Michael E. C.
Linard, Christine
Panigrahy, Dipak
author_facet Robbins, Michael E. C.
Linard, Christine
Panigrahy, Dipak
author_sort Robbins, Michael E. C.
collection PubMed
description
format Text
id pubmed-2896836
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-28968362010-07-07 PPARs and Anticancer Therapies Robbins, Michael E. C. Linard, Christine Panigrahy, Dipak PPAR Res Editorial Hindawi Publishing Corporation 2010 2010-06-08 /pmc/articles/PMC2896836/ /pubmed/20614003 http://dx.doi.org/10.1155/2010/536415 Text en Copyright © 2010 Michael E. C. Robbins et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Robbins, Michael E. C.
Linard, Christine
Panigrahy, Dipak
PPARs and Anticancer Therapies
title PPARs and Anticancer Therapies
title_full PPARs and Anticancer Therapies
title_fullStr PPARs and Anticancer Therapies
title_full_unstemmed PPARs and Anticancer Therapies
title_short PPARs and Anticancer Therapies
title_sort ppars and anticancer therapies
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896836/
https://www.ncbi.nlm.nih.gov/pubmed/20614003
http://dx.doi.org/10.1155/2010/536415
work_keys_str_mv AT robbinsmichaelec pparsandanticancertherapies
AT linardchristine pparsandanticancertherapies
AT panigrahydipak pparsandanticancertherapies